About MoleculeAI
MoleculeAI is a company based in Delhi (India) founded in 2023. It operates as a SaaS and B2B. MoleculeAI offers products and services including MoleculeGEN, ADMET Prediction, Virtual Screening, De Novo Generation, and Lead Optimisation. MoleculeAI operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Delhi, India
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecule Ai Private Limited
- Date of Incorporation 11 Mar, 2023
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$1.66 K (USD)0as on Mar 31, 2024
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MoleculeAI
MoleculeAI offers a comprehensive portfolio of products and services, including MoleculeGEN, ADMET Prediction, Virtual Screening, De Novo Generation, and Lead Optimisation.
Integrated AI tool for de novo molecule generation and lead optimization.
AI-driven prediction of drug absorption and toxicity properties.
Computational method for identifying promising drug molecules.
AI module for creating novel drug-like structures.
Generative AI for enhancing drug candidate properties.
Funding Insights of MoleculeAI
Detailed funding history for MoleculeAI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MoleculeAI
Investment portfolio details for MoleculeAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MoleculeAI
Detailed financials for MoleculeAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Moleculeai Comparisons
Peer comparison for MoleculeAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MoleculeAI
MoleculeAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of MoleculeAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Moleculeai
Complete news archive for MoleculeAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MoleculeAI
MoleculeAI was founded in 2023.
MoleculeAI is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of MoleculeAI is $1.66K as on Mar 31, 2024.
Molecule AI develops AI-based platforms for drug discovery, including MoleculeGEN for generating novel molecules and optimizing leads. Based in Delhi, India, they use computational tools for ADMET prediction, virtual screening, and de novo design to advance biomedical research. Their multidisciplinary team combines AI expertise with chemistry to address unmet needs in healthcare, serving industries focused on innovative drug development.
MoleculeAI's top competitors include Owkin, Formation Bio and XtalPi.
MoleculeAI offers MoleculeGEN, ADMET Prediction, Virtual Screening, De Novo Generation, and Lead Optimisation.